ORAMED PHARMACEUTICALS INC. — All Filings
911 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
10-QT
10KSB
10KSB/A
10QSB
10QSB/A
3
3/A
4
4/A
424B3
424B5
424B7
5
8-A12B
8-A12G
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
EFFECT
FWP
NT 10-K
NT 10-Q
NTN 10Q
POS AM
PRE 14A
PRER14A
REGDEX
RW
S-1
S-1/A
S-3
S-3MEF
S-8
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC 14F1
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | QUARTERLY REPORT | 0001213900-25-044193 | May 15, 2025 | Mar 31, 2025 |
| SCHEDULE 13G/A | — | 0001213900-25-041073 | May 8, 2025 | — |
| SCHEDULE 13D | — | 0001213900-25-038294 | May 1, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-036109 | Apr 28, 2025 | Apr 24, 2025 |
| 10-K | ANNUAL REPORT | 0001013762-25-003450 | Mar 27, 2025 | Dec 31, 2024 |
| 8-K | CURRENT REPORT | 0001213900-25-019437 | Mar 3, 2025 | Feb 28, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-018135 | Feb 27, 2025 | Feb 22, 2025 |
| SCHEDULE 13G/A | — | 0001373604-25-000022 | Feb 13, 2025 | — |
| 4 | — | 0001213900-25-012239 | Feb 11, 2025 | — |
| 4 | — | 0001213900-25-012238 | Feb 11, 2025 | — |
| 4 | — | 0001213900-25-012240 | Feb 11, 2025 | — |
| 4 | — | 0001213900-25-012241 | Feb 11, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-012244 | Feb 11, 2025 | Feb 7, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-005212 | Jan 22, 2025 | Jan 21, 2025 |
| SCHEDULE 13G | — | 0001213900-25-004622 | Jan 17, 2025 | — |
| 4 | — | 0001213900-25-001166 | Jan 6, 2025 | Jan 2, 2025 |
| 4 | — | 0001213900-25-001169 | Jan 6, 2025 | Jan 2, 2025 |
| 4 | — | 0001213900-25-001165 | Jan 6, 2025 | Jan 2, 2025 |
| 4 | — | 0001213900-25-001168 | Jan 6, 2025 | Jan 2, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-000517 | Jan 3, 2025 | Jan 2, 2025 |
| 8-K | CURRENT REPORT | 0001213900-24-109825 | Dec 17, 2024 | Dec 13, 2024 |
| 4 | — | 0001213900-24-095929 | Nov 8, 2024 | Nov 7, 2024 |
| 4 | — | 0001213900-24-095930 | Nov 8, 2024 | Nov 7, 2024 |
| 4 | — | 0001213900-24-095931 | Nov 8, 2024 | Nov 7, 2024 |
| 4 | — | 0001213900-24-095932 | Nov 8, 2024 | Nov 7, 2024 |
| 10-Q | QUARTERLY REPORT | 0001213900-24-095397 | Nov 7, 2024 | Sep 30, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-091795 | Oct 29, 2024 | Oct 24, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-086214 | Oct 8, 2024 | Oct 7, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-082237 | Sep 26, 2024 | Sep 23, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-080812 | Sep 23, 2024 | Sep 20, 2024 |
| SC 13G | — | 0001373604-24-000092 | Sep 16, 2024 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-24-068992 | Aug 14, 2024 | Jun 30, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-064732 | Aug 2, 2024 | Aug 1, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-055950 | Jun 26, 2024 | — |
| 8-K | CURRENT REPORT | 0001213900-24-055006 | Jun 24, 2024 | Jun 20, 2024 |
| 3 | — | 0001213900-24-054773 | Jun 21, 2024 | Jun 18, 2024 |
| 4 | — | 0001213900-24-054781 | Jun 21, 2024 | — |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-24-054007 | Jun 20, 2024 | Aug 1, 2024 |
| ARS | FORM ARS | 0001213900-24-054008 | Jun 20, 2024 | Dec 31, 2023 |
| 4 | — | 0001213900-24-051336 | Jun 10, 2024 | Jun 6, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-051355 | Jun 10, 2024 | Jun 6, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-041847 | May 13, 2024 | May 10, 2024 |
| 10-Q | QUARTERLY REPORT | 0001213900-24-041364 | May 9, 2024 | Mar 31, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-039909 | May 6, 2024 | May 2, 2024 |
| 4 | — | 0001213900-24-034222 | Apr 18, 2024 | Apr 17, 2024 |
| 3 | — | 0001213900-24-029454 | Apr 2, 2024 | Apr 1, 2024 |
| SC 13D | SCHEDULE 13D | 0001213900-24-025263 | Mar 22, 2024 | — |
| 8-K | CURRENT REPORT | 0001213900-24-023721 | Mar 19, 2024 | Mar 14, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-023584 | Mar 18, 2024 | Mar 12, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-023571 | Mar 18, 2024 | — |